Eliem Therapeutics, Inc.

NASDAQ:ELYM

5.11 (USD) • At close October 2, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Assets:
Current Assets:
Cash & Cash Equivalents 87.22993.11243.58546.92220.48721.223
Short Term Investments 63.6913.68679.98189.55800
Cash and Short Term Investments 150.919106.798123.566136.4820.48721.223
Net Receivables 02.0246.492000
Inventory 00-6.4924.39700
Other Current Assets 3.9531.4334.33516.1691.5110.06
Total Current Assets 154.872110.255134.393148.25221.99821.283
Non-Current Assets:
Property, Plant & Equipment, Net 0.490.1990.471000
Goodwill 000000
Intangible Assets 000000
Goodwill and Intangible Assets 000000
Long Term Investments 00024.91900
Tax Assets 000000
Other Non-Current Assets 61.8250.0150.1280.072.6330.112
Total Non-Current Assets 62.3150.2140.59924.9892.6330.112
Total Assets 217.187110.469134.992173.24124.63121.395
Liabilities & Equity:
Current Liabilities:
Account Payables 0.7050.0660.751.4041.0860.647
Short Term Debt 0.1570.6680.6000
Tax Payables 000000
Deferred Revenue 0-0.0660000
Other Current Liabilities 3.3642.0994.7474.6271.9770.136
Total Current Liabilities 4.9312.8336.0976.0313.0630.783
Non-Current Liabilities:
Long Term Debt 0.3750.030.36000
Deferred Revenue Non-Current 000000
Deferred Tax Liabilities Non-Current 000000
Other Non-Current Liabilities 00.007-0.180.00700
Total Non-Current Liabilities 0.3750.0370.180.00700
Total Liabilities 5.3062.876.2776.0383.0630.783
Equity:
Preferred Stock 000173.24146.55126.174
Common Stock 0.0070.0030.0030.0030.0010.001
Retained Earnings -229.876-155.979-120.86-75.616-28.136-7.468
Accumulated Other Comprehensive Income/Loss 0.023-0.002-0.358-0.123-0-0
Other Total Stockholders Equity 441.727263.577249.93242.9393.1521.905
Total Shareholders Equity 211.881107.599128.715167.20321.56820.612
Total Equity 0107.599128.715167.20321.56820.612
Total Liabilities & Shareholders Equity 217.187110.469134.992173.24124.63121.395